MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer. - Adam, Julien; Sourisseau, Tony; Olaussen, Ken A.; Robin, Angélique; Zhu, Chang Q.; Templier, Alexandre; Civet, Alexandre; Girard, Philippe; Lazar, Vladimir; Validire, Pierre; Tsao, Ming S.; Soria, Jean-Charles; et al. (Cancer Biomarkers, 2016)